AI Predicts Vaccine Response from Antibody Patterns — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Arizona State University researchers led a study analyzing blood samples from 4,089 participants, measuring antibodies against 185 antigens to identify pre-vaccination immune patterns linked to vaccine response strength.
- Joshua LaBaer stated that AI analysis of biomarkers can predict who will respond well to vaccines before administration, introducing the concept of 'immune readiness' based on pre-existing antibody signatures.
- Sentinel antibodies targeting pathogens like Staphylococcus aureus, RSV, and human respirovirus 3 were found at higher levels in strong vaccine responders, suggesting they indicate a primed immune system even in healthy individuals.
- AI deep learning models processed millions of immune signals across the full antibody panel, outperforming single-biomarker approaches by capturing complex, interconnected immune states predictive of response.
- About 5% to 6% of healthy participants showed weak responses to COVID-19 vaccination, while some immunosuppressed individuals mounted strong responses, challenging assumptions that health status alone determines vaccine efficacy.
- The study, published in Cell Press Blue, used data from diverse groups including those with HIV, autoimmune disease, and organ transplants, revealing that immune readiness transcends traditional clinical categories.
Why it matters: This shifts vaccine strategy from one-size-fits-all to personalized protection—doctors could identify weak responders in advance, enabling tailored dosing or monitoring. The 5–6% of seemingly healthy people with poor responses represent a previously invisible risk group now detectable before exposure.
Ask SkimNews
